Ysios Capital
Ysios Capital hires Thomas Harth from Gimv
Spanish life sciences VC closed its third life sciences fund in May last year
UCB, Ysios lead EUR 50m Series A for SpliceBio
Round for the gene therapy specialist is the largest ever Series A for a Spanish biotechnology company
Ysios Capital closes third fund on €216m
Fund provides private equity financing to early- and mid-stage life sciences companies
Iberia Fundraising Pipeline - Q1 2021
Unquote compiles a roundup of the most notable fundraises ongoing across the Iberian market, including Magnum, MCH, Suma and more
Sofinnova et al. in €35m series-C round for CorWave
Company has so far raised €80m in funding since being founded in 2012
Iberia Fundraising Pipeline - Q4 2020
Unquote compiles a roundup of the most notable fundraises ongoing across the Iberian market
Novo, Sanofi lead $83m round for Lava Therapeutics
Corporate venture firms were joined by new and existing investors, including Gilde Healthcare
Ysios Capital raises €155m for third biotech fund
Ysios BioFund III provides financing to early- and mid-stage, highly innovative life sciences companies
Asabys leads €20m round for Anaconda Biomed
Previous backers Ysios Capital, Sabadell Venture Capital, Innogest and Omega Funds also take part
Ysios Capital, OrbiMed lead €79m series-C for Galecto
HBM, Bristol Myers-Squibb, Maverick Ventures and Seventure Partners also take part in the round
Fund+ leads €21.3m series-B for Minoryx Therapeutics
Several previous backers and new investors SFPI, SRIW and Sambrinvest also take part in the round
VC firms sell Prexton to Lundbeck for up to €905m
Vendors include Sunstone Capital, Ysios Capital Partners and Forbion Capital Partners
Ysios, Omega lead €15m series-A for Anaconda Biomed
Additional backers include Banco Sabadell and existing investor Innogest Capital
Rothschild et al. lead €34.4m series-B for MedLumics
New VC investors participated in the round, including Italian GP Innogest and Ireland-based Seroba Life Sciences
Ysios et al. raise €15.5m series-B for CorWave
Backers include existing shareholders Sofinnova Partners, BPI France and Seventure Partners
Ysios holds €126.4m final close for second vehicle
Launched with a €100m target, the fund hit its final close after 19 months on the road
Gilde leads €25m series-C for Stat-Diagnostica
Backers include Kurma Partners, Ysios Capital, Idinvest Partners, Caixa Capital Risc and others
Caixa leads €2.2m series-B for Inbiomotion
Existing investors Ysios Capital and Fundación Vila Casas also participated in the round
Ysios et al. in €11.5m series-A for Aelix
Ysios has backed the HIV vaccine developer via its €100m second healthcare-focused fund
Ysios et al. inject €19.4m into Minoryx
Other backers include Kurma, Idinvest and Chiesi
Ysios holds first close on €51.8m
GP expects to raise €100m by September 2015
Gilde Healthcare leads €12.2m AM-Pharma round
Deal marks company's fifth funding round
Kurma leads €17m series-B round for Stat Diagnostica
Kurma Life Sciences Partners has led a €17m series-B round for Spanish medical diagnostics company Stat Diagnostica.
Ysios leads €2m round for Inbiomotion
Ysios Capital has led a €2m series-A funding round for Spanish molecular diagnostics company Inbiomotion.